Literature DB >> 1869747

A novel method to maintain ductus arteriosus patency.

J Y Coe1, P M Olley.   

Abstract

Survival of patients with certain ductal-dependent congenital heart diseases depends on continued patency of the ductus arteriosus or the surgical creation of an aortopulmonary shunt. The latter may be difficult in the presence of hypoplastic pulmonary arteries. Long-term prostaglandin therapy may be used to maintain ductal patency but is not without limitation and side effects. This experimental study describes a novel approach to maintain ductal patency with a stainless steel stent. Six newborn lambs less than or equal to 48-h old had a ductal stent placed during right heart catheterization. Two lambs less than 36-h old had a stent delivered by the arterial route. The stent was delivered and released at the target with relative ease and no incidence of embolization. Continued ductal patency up to 3 months was demonstrated by repeat cardiac catheterization and angiography, two-dimensional color Doppler echocardiography and postmortem examination. The experimental model provides a left to right shunt model in which the size may be increased as the animal grows. More important, a ductal stent could be used to maintain ductal blood flow in neonates and infants with ductal-dependent cardiac malformations, thereby avoiding a thoracotomy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869747     DOI: 10.1016/0735-1097(91)90810-v

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Hybrid palliation for neonates with hypoplastic left heart syndrome: current strategies and outcomes.

Authors:  Osami Honjo; Christopher A Caldarone
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

2.  Occlusion of the neonatal patent ductus arteriosus with a simple retrievable device: a feasibility study.

Authors:  M B Neuss; J Y Coe; F Tio; T P Le; R Grabitz; D A Redel
Journal:  Cardiovasc Intervent Radiol       Date:  1996 May-Jun       Impact factor: 2.740

3.  Stenting the arterial duct.

Authors:  J L Gibbs
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

4.  Patent ductus arteriosus stenting in complex congenital heart disease: early and midterm results for a single-center experience at children hospital, Mansoura, Egypt.

Authors:  Mohamed Matter; Hala Almarsafawey; Mona Hafez; Gehan Attia; Mohamed-Magdy Abuelkheir
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

5.  Histopathologic evaluation of patent ductus arteriosus stents after hybrid stage I palliation.

Authors:  Matthew J Egan; Aaron J Trask; Peter B Baker; Jonathan Lawrence; Elena Ladich; Renu Virmani; Sharon L Hill; John P Cheatham; Mark Galantowicz; Pamela A Lucchesi; John P Kovalchin
Journal:  Pediatr Cardiol       Date:  2011-02-05       Impact factor: 1.655

6.  Ductus Arteriosus Stenting in Newborns - Transcatheter Approach as a Bridge Therapy for Corrective Surgery.

Authors:  Hiyam Mahmoud; Tammam Youssef; Eliza Cinteza; Cristiana Voicu; Adrian Balan; Irina Margarint; Cristina Filip; Georgiana Nicolae; Gabriela Duica; Alin Nicolescu; Ileana Barascu; Catalin Cirstoveanu
Journal:  Maedica (Bucur)       Date:  2022-03

7.  Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome.

Authors:  J L Gibbs; C Wren; K G Watterson; S Hunter; J R Hamilton
Journal:  Br Heart J       Date:  1993-06

8.  Axillary artery access for cardiac interventions in newborns.

Authors:  Dietmar Schranz; Ina Michel-Behnke
Journal:  Ann Pediatr Cardiol       Date:  2008-07

9.  The role of stents in the treatment of congenital heart disease: Current status and future perspectives.

Authors:  Bjoern Peters; Peter Ewert; Felix Berger
Journal:  Ann Pediatr Cardiol       Date:  2009-01

Review 10.  A review of ductal stenting in hypoplastic left heart syndrome: bridge to transplantation and hybrid stage I palliation.

Authors:  D J DiBardino; D B McElhinney; A C Marshall; E A Bacha
Journal:  Pediatr Cardiol       Date:  2007-10-03       Impact factor: 1.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.